v3.26.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
$ in Thousands
12 Months Ended
Dec. 31, 2025
USD ($)
Integer
Dec. 31, 2024
USD ($)
Product Information [Line Items]    
Asset impairments | $ $ 0 $ 0
Research and development expense | $ $ 2,347 $ 1,977
Operating segment | Integer 1  
Reportable segment | Integer 1  
Accounts Receivable [Member] | Customer Concentration Risk [Member] | One Customers [Member]    
Product Information [Line Items]    
Concentration risk, percentage 16.00%  
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Three Customers [Member]    
Product Information [Line Items]    
Concentration risk, percentage   85.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Customers [Member]    
Product Information [Line Items]    
Concentration risk, percentage 31.00% 34.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Three Customers [Member]    
Product Information [Line Items]    
Concentration risk, percentage   15.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member]    
Product Information [Line Items]    
Concentration risk, percentage 15.00% 22.00%